Sacral Neurostimulation reasonable to treat chronic Idiopathie constipation Ghislain Devroede Département de chirurgie Faculté de médecine et des Sciences.

Slides:



Advertisements
Similar presentations
The use of PTQ anal bulking injections
Advertisements

US TOO INTERNATIONAL, INC US TOO GREATER QUAD CITIES PROSTATE CANCER SUPPORT GROUP.
INTRODUCING THE RELIEF REGISTRY Dr. Jaron Rabinovici Sheba Medical Center, Israel.
ACRIN 6673 MULTICENTER FEASIBILITY STUDY OF PERCUTANEOUS RADIOFREQUENCY ABLATION OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS Final Report from Central.
6/9/2015F. Atashzadeh1. Fecal incontinence related to pregnancy, vaginal delivery, and cesarean Foroozan Atashzadeh Shorideh PhD nursing Candidate, Shahid.
Commission on Cancer Update for Massachusetts Cancer Liaison Physicians Massachusetts Chapter American College Surgeons Peter Hopewood MD FACS.
Physiotherapy approaches for urgency and urge incontinence Liz Childs Pelvic Health Physiotherapist.
Communicating Effectively with Health Care Providers.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Consultant Colorectal Surgeon
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Urinary Incontinence in women. Urinary incontinence Stress – involuntary leakage of urine on effort, sneezing or coughing Urgency – involuntary leakage.
Sacral Nerve Stimulation: Critical Update and Literature Review
Ghislain Devroede Département de chirurgie Faculté de médecine et des Sciences de la Santé Université de Sherbrooke Québec, Canada.
University of California, Irvine
Mak KS, 1 Miller RC, 2 Krishnan S, 3 Laperriere N, 4 Micke O, 5 Rutten I, 6 Kadish SP, 7 Ozsahin M, 8 and Mirimanoff RO 8 1 Harvard Medical School, Boston,
USUHS MSIII Ob/Gyn Clerkship Self Directed Studies Incontinence Ch Academic Year MSIII Ob/Gyn Clerkship Self-Directed Study.
Role of surgery in treatment of fecal incontinence disorders Rasoul Azizi M.D Colo-Rectal Surgeon Associate Professor of surgery School of Medical Sciences,
Disability and Incontinence Patient assessment Patient management.
Experiences in Sacral Neuromodulation for the Treatment of Fecal Incontinence Stephen Cohen, MD, FACS, FASCRS Associate Clinical Professor Emory University.
The National Program of Cancer Registries: Enhancing Cancer Incidence Data … Hannah K. Weir, PhD Division of Cancer Prevention and Control Centers for.
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients Assessment.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Results of the Vivitrol Pilot in Los Angeles County Presented by: Desiree A. Crevecoeur-MacPhail, Ph.D. Research Psychologist, UCLA ISAP.
National Center for Policy Analysis Making Ideas Change the World Myths About National Health Insurance.
Constipation WHO, WHAT, WHEN M E S Kiff. Review: Surgery,constipation  Google: 1,730,000  Google scholar: 15,000  PubMed: 2453  Last 500 papers.
This presentation has been created for colorectal surgeons who implant InterStim to discuss the therapy with referring clinician groups.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
HEALH CARE DELIVERY SYSTEM General Hospital l Facility where patients are hospitalized a short time (few days to a few weeks) l Provide a wide range.
Matthew S. Slater, MD, Brian S. Diggs, PhD Frederick A. Tibayan, MD Steven G Guyton, MD, MPH Howard K. Song, MD, PhD The Department of Surgery, and the.
Geography of the United States the-united-states-of-america ?op=1.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
The Effects of Deep Brain Stimulation on the Motor Symptoms of Parkinson’s Disease Aaron Mulheren Kathryn Wilson, MSN, APN Milind Deogaonkar, MD Science.
Chang Gung University Lai-Chu See, Ph.D. Professor Department of Public Health, College of Medicine, Chang Gung University, Taiwan
Chapter 39 Elimination Fundamentals of Nursing: Standards & Practices, 2E.
How Welfare and Employment Policies Affect Children Beth Clark-Kauffman Greg J. Duncan Northwestern University Pamela Morris MDRC.
Centre of Academic Surgery Barts and The London Queen Mary’s School of Medicine and Dentistry EXternal Pelvic REctal SuSpension Using Permacol Implant.
U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics Division of Vital Statistics.
GERIATRIC EDUCATION SERIES Presented in partnership by Funded in part by a grant from the EJC Foundation.
Trends and Characteristics of Home Births in the United States Marian MacDorman,* Eugene Declercq,** T.J. Mathews* *National Center for Health Statistics.
 An abortion is the termination of a pregnancy by the removal or expulsion of an embryo or fetus from the uterus, resulting in or caused by its death.
Anders Mellgren, MD, PhD, FACS, FASCRS Clinical Professor of Surgery Division of Colon & Rectal Surgery University of Minnesota Director, Pelvic Floor.
Harold I Perl, PhD Center for the Clinical Trials Network National Institute on Drug Abuse 8 th Conference of INEBRIA Boston, MA September 23, 2011.
David Spellberg, MD Naples Urological Associates High Intensity Focused Ultrasound Sonablate ® HIFU A Minimally Invasive Way to Treat Prostate Cancer.
What you need to know about Prostate Cancer. Brian McGarry’s Story 1/30/2014 To: DCS Faculty From: Brian McGarry Patty and I received news in the last.
Which Method Is More Effective In Treatment Of Calcific Tendinitis In The Shoulder? - Prospective Randomized Comparison Between US- Guided Needling and.
Trauma and Child Brain Development: the physiological impact of traumatic stress and implications service systems Joshua Arvidson, MSS., LCSW Alaska Child.
Pudendal Nerve Entrapment
INTERSTIM ® THERAPY for Urinary Control. What are Bladder Control Problems? Broad range of symptoms –May leak small or large amount of urine –May leak.
Fears About HIV Transmission in Families with an HIV-Infected Parent: A Qualitative Analysis Burton O. Cowgill, MPH 1,2 ; Laura M. Bogart, PhD 3 ; Rosalie.
Low Anterior Resection Syndrome
The Emergence of Therapeutic Neurostimulation: Reducing Barriers to Innovation and Growth John Reppas MD- PhD Director of Public Policy American Society.
©2015 MFMER | slide-1 PTSD: Worsening outcomes for comorbid depression… even with collaborative care management. Kurt B. Angstman, MS, MD Professor of.
Lecture Fifteen Biomedical Engineering for Global Health.
Percutaneous Nerve Evaluation Test Versus Staged Test Trials for Sacral Neuromodulation: Sensitivity, Specificity, and Predictive Values of Each Technique.
CLINICAL SIGNIFICANCE
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
InterstimTM for bowel dysfunction
METHODS AND MATERIALS: SCIENTIFIC/CLINICAL SIGNIFICANCE:
Sacral Neuromodulation in Patients With a Cardiac Pacemaker
Success of a repeated tined lead trial in a refractory OAB population
Predictors of Longterm Sacral Nerve Stimulation Failures
Parkinson’s progression markers initiative
New CHEST Editorial Board Members
New CHEST Editorial Board Members
Initial Office Evaluation
Initial Office Evaluation for OAB
From Innovation to Commercialization Access to Data
Presentation transcript:

Sacral Neurostimulation reasonable to treat chronic Idiopathie constipation Ghislain Devroede Département de chirurgie Faculté de médecine et des Sciences de la Santé Université de Sherbrooke Québec, Canada

QUALITY OF LIFE IS MARKEDLY IMPROVED IN PATIENTS WITH FECAL INCONTINENCE AFTER SACRAL NERVE STIMULATION

*SNS STUDY GROUP (in alphabetical order) The SNS Study Group included the following members (in alphabetical order): Jennifer M. Ayscue, MD, Washington Hospital Center, Washington, DC; Miranda Chan, MD, Department of Surgery, Kwong Wah Hospital, Hong Kong SAR, China; Heidi Chua, MD, Mayo Clinic, Rochester, MN; John A. Coller, MD, Department of Colon and Rectal Surgery, Lahey Clinic, Burlington, MA; Ghislain Devroede, MD, Department of Surgery, Centre Hospitalier Universitaire de Sherbrooke, Fleurimont, Canada; Michael England, MD, Norman F. Gant Research Foundation, Forth Worth, TX; Tracy Hull, MD, Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH; Howard Kaufman, MD, Division of Colorectal Surgery, University of Southern California, Los Angeles, CA; Robert D. Madoff, MD, Division of Colon & Rectal Surgery, University of Minnesota, MN; David Margolin, MD, Department of Colon & Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA; Richard McCallum, MD, University of Kansas Medical Center, Kansas City, KS; Anders Mellgren, MD, PhD, Division of Colon & Rectal Surgery, University of Minnesota, MN; Ece Mutlu, MD, Rush University Medical Center, Chicago, IL; Deborah Nagle, MD, Colon and Rectal Surgical Division, Beth Israel Deaconess Medical Center, Boston, MA; Susan Parker, MD, Division of Colon & Rectal Surgery, University of Minnesota, MN; Paul Pettit, MD, Mayo Clinic, Jacksonville, FL; Abbas S. Shobeiri, MD, University of Oklahoma, Oklahoma City, OK; William J. Snape, MD, California Pacific Medical Center, San Francisco, CA; Joe Tjandra, MD (Late), Royal Melbourne Hospital, Victoria, Australia; Steven D. Wexner, MD, Department of Colorectal Surgery, Cleveland Clinic Florida, FL.

Sacral Nerve Stimulation (SNS) SNS usually stimulates S Europe - Chronic pelvic and lower urinary and intestinal tract disorders 1997/1999 USA - UI / UF and Retention 2011 USA - Chronic fecal incontinence Note: FDA's approval is based solely on 12-month data.

SNS Therapy Staged Procedure Electrode in S3 Test stimulation days Implantation

Sacral nerve stimulation for fecal incontinence ______________________________________________________ North American SNS Study Group (FDA Approved Protocol) Informed consent :285 Test stimulation :133 (152 rejected by inclusion / (tined lead electrode) exclusion criteria) Interstim Device :120 (47%) Follow up (years) :5 (0.2 – 7.0)

Frequency of incontinent episodes or days per week (follow-up to baseline : P <.001) 3 6

Percent of patients with >50% improvement in incontinent episodes per week

Fecal incontinence severity index assessment (FISI) (follow-up to baseline : P <.001) 3 6

Fecal incontinence quality of life assessment (FIQOL score) (follow-up to baseline : P <.001) 3 6

Score improvement for each question of the FIQOL Note: Question 1 rating “general state of health” has a reverse scale, with 1 being “Excellent” and 5 being “Poor”. The other questions use a scale of 1-4, with 1 being worse and 4 being best.

Individual QOL questions at baseline and 48 months

Improved quality of life after sacral neurostimulation for fecal incontinence FOOD:Amount Restaurants SOCIAL:Going out (movies, church, friends) Staying overnight away from home Traveling (trains, plane) (ALL P < 0.001) n = 120

Improved quality of life after sacral neurostimulation for fecal incontinence INTIMACY:Less frequent sexual encounters than wished Fears of sexual encounters FEELINGS:Different Not enjoying life Ashamed Depressed (ALL P < 0.001) n = 120

Sacral nerve stimulation or modulation ? We know for sure that we stimulate : Variables :- sacral root - body side - voltage - frequency - sensation site (anus, perineal body, vulva) - anal contraction; toe movement We do not know what we modulate

There is focal brain activation during sacral nerve stimulation (L. LUNDBY, A. MOLLER, S. BUNTZEND, K. KROGH, K. VANG, A. GJEDDE, S. LAURBERG, Diseases of the Colon & Rectum 2011; 54; )

Sacral neurostimulation The Sherbrooke experience Percutaneous nerve stimulation (PNS) :81 (extended PNE to days)(2 sides = 162 PNEs) Interstim sacral nerve stimulation (SNS) : 68 (AS OF 1/12/2012)

The ghost of my mother ______________________________________________________ RC :Fecal incontinence by pudendal neuropathy (no effective treatment) Preoperative decision: Wexner 17/20 Anal electromyography : Pudendal neuropathy (EAS/PR) Functional rectal examination : Pudendal neuropathy Interstim implant: Wexner 0/20 SNS Off: Wexner 0/20 No visit for one year SNS Out: Wexner 0/20 Suzanne L.

The ghost of my mother ______________________________________________________ « My mother never loved me » BIRTH :Her mother gives her in adoption Her father brings her back home ORPHAN OF HER FATHER ORPHAN OF HER MOTHER : She is disinherited 21/9/2011 :« Don't say I'm crazy » «The corpse of my dead mother came into my bed. My guardian angel, at the ceiling told me I was cured. » SNS OFFGoes to the Dominican Republic Goes to Mexico No fecal incontinence 23/11/2012 :Interstim removed Suzanne L.

Risk factors for female fecal incontinence 5 BHARUCHA 2006 n = 5300 AGE (per decade ) IBSDIARRHEAANAL FISTULA URGENCY (NO DIARRHEA NO CONSTIPATION) VAGINAL DELIVERY FORCEPS STITCHES ODDS RATIOS

A NEAR MISS ______________________________________________________ WEXNER SCORE FIRST VISIT18/20 SECOND VISIT11/20 THIRD VISIT 4/20 (dismissed)(daily clean pads) Pauline D.

A NEAR MISS ______________________________________________________ Pregnant mother, dying father (Hodgkin’s disease) 9 months old :Death of father Maternal grandmother :Accuses her daughter-in-law of having « killed » her son ____________________________ “You were like a strong wind opening a door widely” “I knew for a long time I was mother to my mother” “You told me she was more attached to me, and needing me, than loving me” Pauline D.